Featured Insights

  1. The Bumpy Road Ahead: Stakeholder Perspectives On EU HTAR 1/17/2025

    Experts convened at ISPOR Europe 2024 to discuss the upcoming EU Health Technology Assessment Regulation (EU HTAR), sharing insights and lessons learned from recent national reforms.

  2. Anticipating The Top Market Access Trends Globally For 2025 1/3/2025

    Navigate the shifting healthcare landscape that lies ahead. This report explores policy changes, market access trends, and strategies for ensuring patient access to innovative therapies.

  3. Biopharmaceutical Manufacturing Conference: Embracing Technology And Innovation 11/6/2024

    Industry leaders gathered at the PDA Ireland Chapter event to discuss how innovation and technology are transforming biopharmaceutical manufacturing, addressing challenges, and driving efficiency.

  4. Best Practices In The Design Of A Pharmaceutical Manufacturing Facility 11/6/2024

    A well-designed manufacturing facility is critical to ensuring product quality and regulatory compliance. Let's examine the importance of the concept design review in achieving these goals.

  5. How To Navigate The EU HTA Regulation For Better Market Access 10/21/2024

    The EU's new Health Technology Assessment Regulation poses challenges and opportunities for the biopharma industry, making manufacturers adapt to unpredictable PICOs and prioritize scenario planning.

  6. Empowering Healthcare Decision-Making 10/21/2024

    FormularyDecisions, now part of Cencora, has evolved significantly since its acquisition in 2019. Let's reflect on its journey, impact, and the future of formulary submissions in the digital age.

  7. The Unintended Consequences Of The Inflation Reduction Act (IRA) 10/21/2024

    Cencora PayerPulse provides insights into market access trends and the Inflation Reduction Act's impact on Medicare Part D, based on research from 41 advisors.

  8. Industry Insights In Isolator Technologies And Aseptic Processing In Pharma 8/30/2024

    Explore an overview of trends and insights in isolator technologies and aseptic processing in the pharmaceutical industry.

  9. What The Shift To The EMA's PMS Means For Industry 8/30/2024

    Explore the implications of the shift to the European Medicines Agency's Pharmacovigilance System Master File (PMS) database for the pharmaceutical industry.

  10. Balancing Customization And Standardization With Targeted Medicines 8/30/2024

    Examine an overview of the challenges companies face in handling regulatory differences when manufacturing targeted medicines.